Vistin Pharma Balance Sheet Health
Financial Health criteria checks 5/6
Vistin Pharma has a total shareholder equity of NOK310.7M and total debt of NOK5.6M, which brings its debt-to-equity ratio to 1.8%. Its total assets and total liabilities are NOK387.9M and NOK77.2M respectively. Vistin Pharma's EBIT is NOK82.7M making its interest coverage ratio -20.1. It has cash and short-term investments of NOK5.6M.
Key information
1.8%
Debt to equity ratio
NOK 5.64m
Debt
| Interest coverage ratio | -20.1x |
| Cash | NOK 5.63m |
| Equity | NOK 310.74m |
| Total liabilities | NOK 77.21m |
| Total assets | NOK 387.94m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: VP4's short term assets (NOK143.8M) exceed its short term liabilities (NOK67.4M).
Long Term Liabilities: VP4's short term assets (NOK143.8M) exceed its long term liabilities (NOK9.8M).
Debt to Equity History and Analysis
Debt Level: VP4's net debt to equity ratio (0%) is considered satisfactory.
Reducing Debt: VP4's debt to equity ratio has increased from 0% to 1.8% over the past 5 years.
Debt Coverage: VP4's debt is well covered by operating cash flow (1770%).
Interest Coverage: VP4 earns more interest than it pays, so coverage of interest payments is not a concern.